Cited 0 times in
Correction of target-controlled infusion following the wrong selection of emulsion concentration of propofol
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | 채, 윤정 | - |
dc.contributor.author | 이, 원일 | - |
dc.date.accessioned | 2015-10-28T23:56:59Z | - |
dc.date.available | 2015-10-28T23:56:59Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/11841 | - |
dc.description.abstract | Background: We investigated the correction methods following wrong-settings of emulsion
concentrations of propofol as a countermeasure against erroneous target-controlled infusions (TCI). Methods: TCIs were started with targeting 4.0 μg/ml of effect-site concentration (Ceff) of propofol, and the emulsion concentrations were selected for 2.0% instead of 1.0% (FALSE1- 2, n = 24), or 1.0% instead of 2.0% (FALSE2-1, n = 24). These wrong TCIs were corrected at 3 min after infusion start. During FALSE1-2, the deficit was filled up while injecting after equilibrium (n = 12), or while overriding (n = 12). During FALSE2-1, the overdose was evacuated while targeting Ceff (n = 12) or targeting plasma concentration (Cp) (n = 12). The gravimetrical measurements of TCI reproduced the Cp and Ceff using simulations. The reproduced Ceff at 3 min (Ceff-3min) and the time to be normalized within ± 5% of target Ceff (T±5%), were compared between the correction methods. Results: During the wrong TCI, Ceff-3min was 1.98 ± 0.01 μg/ml in FALSE1-2, and 7.99 ± 0.05 μg/ml in FALSE2-1. In FALSE1-2, T±5% was significantly shorter when corrected while overriding (3.9 ± 0.25 min), than corrected after equilibrium (6.9 ± 0.05 min) (P < 0.001). In FALSE2-1, T±5% was significantly shorter during targeting Cp (3.6 ± 0.04 min) than targeting Ceff (6.7 ± 0.15 min) (P < 0.001). Conclusions: The correction methods, based on the pharmacokinetic and pharmacodynamic characteristics, could effectively and rapidly normalize the wrong TCI following erroneously selections of the emulsion concentration of propofol. | - |
dc.description.tableofcontents | Ⅰ.INTRODUCTION 1
Ⅱ.MATERIALS AND METHODS 2 Ⅲ.RESULTS 7 Ⅳ.DISCUSSION 11 Ⅴ.CONCLUSION 15 | - |
dc.language.iso | en | - |
dc.title | Correction of target-controlled infusion following the wrong selection of emulsion concentration of propofol | - |
dc.title.alternative | 목표농도주입법에서 프로포폴 농도를 잘못 설정 후 교정 방법 | - |
dc.type | Thesis | - |
dc.identifier.url | http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000019017 | - |
dc.subject.keyword | Drug delivery systems | - |
dc.subject.keyword | Infusion pumps | - |
dc.subject.keyword | Intravenous infusion | - |
dc.subject.keyword | Propofol | - |
dc.subject.keyword | 약물 전달 시스템 | - |
dc.subject.keyword | 주입 펌프 | - |
dc.subject.keyword | 정맥 주입 | - |
dc.description.degree | Master | - |
dc.contributor.department | 대학원 의학과 | - |
dc.contributor.affiliatedAuthor | 이, 원일 | - |
dc.date.awarded | 2015 | - |
dc.type.local | Theses | - |
dc.citation.date | 2015 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.